What makes MUC1 a tumor antigen? (Q36188575)

12 August 2017

1 reference

title

What makes MUC1 a tumor antigen? (English)

1 reference

12 August 2017

Uwe Karsten

1

1 reference

12 August 2017

Silvia von Mensdorff-Pouilly

series ordinal

2

1 reference

12 August 2017

Steffen Goletz

series ordinal

3

1 reference

12 August 2017

6 July 2005

1 reference

12 August 2017

1 reference

12 August 2017

26

1 reference

12 August 2017

4

1 reference

12 August 2017

217-220

1 reference

https://scigraph.springernature.com/pub.10.1159/000086956

12 August 2017

0 references

cites work

MUC1 immunobiology: from discovery to clinical applications

1 reference

A mechanism for inhibition of E-cadherin-mediated cell-cell adhesion by the membrane-associated mucin episialin/MUC1.

21 January 2018

1 reference

Mechanisms underlying aberrant glycosylation of MUC1 mucin in breast cancer cells.

21 January 2018

1 reference

Role of E box and initiator region in the expression of the rat follicle-stimulating hormone receptor

21 January 2018

1 reference

O-linked glycosylation in the mammary gland: changes that occur during malignancy.

21 January 2018

1 reference

21 January 2018

Tumor marker workshops

1 reference

Binding patterns of DTR-specific antibodies reveal a glycosylation-conditioned tumor-specific epitope of the epithelial mucin (MUC1).

21 January 2018

1 reference

Probing the conformational and dynamical effects of O-glycosylation within the immunodominant region of a MUC1 peptide tumor antigen

21 January 2018

1 reference

NMR-based determination of the binding epitope and conformational analysis of MUC-1 glycopeptides and peptides bound to the breast cancer-selective monoclonal antibody SM3.

21 January 2018

1 reference

Glycosylation affects both the three-dimensional structure and antibody binding properties of the HIV-1IIIB GP120 peptide RP135.

21 January 2018

1 reference

Complex carbohydrates are not removed during processing of glycoproteins by dendritic cells: processing of tumor antigen MUC1 glycopeptides for presentation to major histocompatibility complex class II-restricted T cells

21 January 2018

1 reference

A glycopeptide in complex with MHC class I uses the GalNAc residue as an anchor

21 January 2018

1 reference

O-Linked glycans control glycoprotein processing by antigen-presenting cells: a biochemical approach to the molecular aspects of MUC1 processing by dendritic cells

21 January 2018

1 reference

Therapeutic peptides and peptidomimetics

21 January 2018

1 reference

Selection of large diversities of antiidiotypic antibody fragments by phage display

21 January 2018

1 reference

Antitumor vaccines: is it possible to prevent a tumor?

21 January 2018

1 reference

Cancer vaccines: between the idea and the reality

21 January 2018

1 reference

Colonic Tumor CEA, CSAp and MUC-1 Expression following Radioimmunotherapy or Chemotherapy

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000086956

1 reference

Dimensions Publication ID

12 August 2017

0 references

1 reference